GLP Receptor Agonist Compounds

GLP receptor agonists are research peptides that engage the incretin family of class B G-protein-coupled receptors, primarily GLP-1R, GIP-R, and the glucagon receptor, to study signaling cascades involved in glucose homeostasis, satiety pathways, and energy metabolism in preclinical models. This category covers mono-agonists (single-receptor targeting), dual agonists (GLP-1/GIP, GLP-1/glucagon), and tri-agonists (GLP-1/GIP/glucagon) used as research analogs of the endogenous incretin signaling system.

Each compound in this category is synthesized via solid-phase peptide synthesis, purified to 99%+ via reverse-phase HPLC, and identity-confirmed by mass spectrometry. Compounds are studied in controlled laboratory settings to examine receptor binding affinity, downstream cAMP / β-arrestin signaling, structural stability under physiological pH and temperature ranges, and comparative pharmacology against reference agonists. All material is intended exclusively for in vitro and in vivo research applications.